Cited 0 times in Scipus Cited Count

An updated review of mucosal melanoma: Survival meta-analysis

DC Field Value Language
dc.contributor.authorHahn, HM-
dc.contributor.authorLee, KG-
dc.contributor.authorChoi, W-
dc.contributor.authorCheong, SH-
dc.contributor.authorMyung, KB-
dc.contributor.authorHahn, HJ-
dc.date.accessioned2022-01-14T05:21:01Z-
dc.date.available2022-01-14T05:21:01Z-
dc.date.issued2019-
dc.identifier.issn2049-9450-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/20198-
dc.description.abstractMucosal melanoma (MM) is a highly lethal variant of melanoma that carries a poor prognosis. Extremely low incidence and survival rates have led to few clinical trials, and a lack of protocols and guidelines. The present study performed a survival meta-analysis for the quantitative synthesis of available evidence to search for key patterns that would help clinicians tailor optimal therapeutic strategies in MM. PubMed, EMBASE, Cochrane, MEDLINE, Google Scholar and other databases were searched. Hazard ratios, in disease-specific and overall survival, were calculated for each of the survival-determining variables. MM was 2.25 times more lethal than cutaneous melanoma (CM). The most significant threats to survival were advanced Tumor-Node-Metastasis stage, sino-nasal location, and old age. Chemotherapy was the most effective form of adjuvant therapy. Disease-specific survival, the primary measure of the effect sizes, can fluctuate depending on the accuracy of the reported cause of mortality. In conclusion, MM is a peculiar type of melanoma, with clinical and molecular profile vastly different from the much-familiar CM. In the wake of the era of precision oncology, further studies on driver mutations and oncogenic pathways would likely lead to improved patient survival.-
dc.titleAn updated review of mucosal melanoma: Survival meta-analysis-
dc.typeArticle-
dc.identifier.pmid31281645-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589937/-
dc.subject.keywordHR-
dc.subject.keywordMM-
dc.subject.keywordOS-
dc.subject.keyworddisease-specific survival-
dc.subject.keywordsurvival meta-analysis-
dc.contributor.affiliatedAuthorHahn, HM-
dc.type.localJournal Papers-
dc.identifier.doi10.3892/mco.2019.1870-
dc.citation.titleMolecular and clinical oncology-
dc.citation.volume11-
dc.citation.number2-
dc.citation.date2019-
dc.citation.startPage116-
dc.citation.endPage126-
dc.identifier.bibliographicCitationMolecular and clinical oncology, 11(2). : 116-126, 2019-
dc.identifier.eissn2049-9469-
dc.relation.journalidJ020499450-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Plastic & Reconstructive Surgery
Files in This Item:
31281645.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse